Obseva: The power of the GnRH antagonist MoA to personalize fibroid management

P C
1 December 2021

Obseva: The power of the GnRH antagonist MoA to personalize fibroid management

Obseva: The power of the GnRH antagonist MoA to personalize fibroid management https://seud.org/wp-content/uploads/2024/02/VIOD-SYMPO-1.jpg 1919 1080 P C P C https://seud.org/wp-content/plugins/ultimate-member/assets/img/default_avatar.jpg 1 December 2021 1 December 2021

Chapters

Introduction – The E2 theory and Linzagolix: a new oral GnRH antagonist, Felice Petraglia (Italy)
Heavy menstrual bleeding due to uterine fibroids: Lingazolix efficacy and safety, Hugh Taylor (USA)
Hormonal add-back therapy in the treatment of uterine fibroids, Jacques Donnez (Belgium)

Obseva: The power of the GnRH antagonist MoA to personalize fibroid management

Obseva: The power of the GnRH antagonist MoA to personalize fibroid management

Chapters

Should endometriosis women with infertility with age>35 years do IVF before laparoscopic surgery? – Y. Yu (China)

Free communication #7: uterine fibroids

Contact: SEUD secretariat